Amendment to Schedule 13D for Alzamend Neuro, Inc.

This filing is an amendment to Schedule 13D for Alzamend Neuro, Inc., disclosing changes in beneficial ownership of the company's common stock. The amendment includes detailed information on the number of shares owned by various entities and individuals, including Milton C. Ault, III, William B. Horne, Henry C.W. Nisser, Kenneth S. Cragun, and David J. Katzoff. The filing also outlines the sources of funds used to acquire these securities and provides a breakdown of voting and dispositive powers. Additionally, it includes transactions in the Series B Convertible Preferred Stock and common stock over the past 60 days. The filing is significant as it reflects changes in ownership and control that could impact the company's governance and strategic direction.